Song yan Rui

Song yan Rui China

Sole Arbitrator Emergency Arbitrator Member of the arbitral tribunal Mediator Associated Mediator Expert
China Chinese (China) Resident in China Chinese — Fluent English — Intermediate

Surname
Rui
First name
Song yan
Current professional position
Senior counsel
Organisation / firm
China associated team of Bird & Bird LLP
Country of residence
China
Nationality
Chinese (China)
Languages spoken & proficiency
ChineseFluent EnglishIntermediate

Arbitrator roles
Sole Arbitrator Emergency Arbitrator Member of the arbitral tribunal
Mediator roles
Mediator Associated Mediator
Expert
Expert
Professional biography
Rui Songyan is a former Senior Judge and Member of the Judicial Committee of the Beijing Intellectual Property Court, and currently practises as Senior Counsel within the China Associated Team of Bird & Bird LLP. She holds a doctoral degree in law and has devoted 24 years to the judicial field of intellectual property rights. As a senior and authoritative expert in intellectual property judicial protection in China, she has been honored as "One of the Top 10 Young Jurists in the Capital" and "Beijing Judicial Trial Expert". She has presided over more than 3,000 intellectual property cases of various types and participated in the trial of over 5,000 cases, including more than 500 foreign-related cases covering patents, SEPs, pharmaceutical patent linkage, trademarks, copyrights, unfair competition, anti-monopoly and other full fields. She was the judge in China with relatively comprehensive experience in hearing various types of SEP cases. she has presided over SEP cases involving 2G, 4G and 5G communication standards, covering cutting-edge global controversial issues such as licensing rate calculation for terminals, chips and base stations, FRAND obligation determination and injunctive relief. As the first presiding judge of pharmaceutical patent linkage cases in China, She has presided over more than 200 foreign-related pharmaceutical patent cases and established core judicial rules for this field in China. The first case she heard in this area was selected as one of the Top 10 Cases by the Supreme People's Court, granting her irreplaceable professional advantages in pharmaceutical patent dispute resolution. She is proficient in the cross-cutting rules of intellectual property law and anti-monopoly law. and has presided over many foreign-related anti-monopoly cases that have filled judicial gaps in China, and her judgments have been hailed by the industry as benchmarks in civil anti-monopoly litigation. she is capable of handling complex cross-disputes involving patents and anti-monopoly under the UPC framework. She has accumulated at least hundreds of hours of hands-on mediation practice. She excels at facilitating dispute resolution through structured court proceedings and professional communication. she has presided over many globally significant SEP cases including Samsung v. Huawei, OPPO v. Nokia, and Huawei v. MediaTek, all of which have finally reached global settlements. Among the more than 200 foreign-related pharmaceutical patent linkage cases she has presided over, more than half were concluded by withdrawal of claims based on mediation agreements reached by both parties. she has the mature ability to efficiently preside over mediation, advance arbitration proceedings and facilitate comprehensive resolution of cross-border disputes.

Mediations conducted
More than 200
25 years in this role

Legal / dispute expertise
Antitrust / competition law Copyrights & related rights Dispute resolution / arbitration practice National patents SEPs / FRAND Trade secrets & know-how Trademarks Unfair competition
Technical expertise
Artificial intelligence / data technologies Chemistry Pharmaceutics
Industries
Construction & engineering Energy & utilities Pharmaceuticals & life sciences Technology & IT Telecommunications

Bar admission(s)
People ’s Republic of China
Governing law experience
Civil law
Mediation style
Evaluative Facilitative Transformative
Brief description

She has accumulated at least hundreds of hours of hands-on mediation practice. She excels at facilitating dispute resolution through structured court proceedings and professional communication. she has presided over many globally significant SEP cases including Samsung v. Huawei, OPPO v. Nokia, and Huawei v. MediaTek, all of which have finally reached global settlements. Among the more than 200 foreign-related pharmaceutical patent linkage cases she has presided over, more than half were concluded by withdrawal of claims based on mediation agreements reached by both parties.

Education (degrees)
Doctoral Degree in Intellectual Property Law 9/2011 –6/ 2015.Graduate School of the Chinese Academy of Social Sciences |Master's Degree in International Law. 9/ 1999 – 7 /2002.Graduate School of China University of Political Science and Law
Certifications / licenses
Qualification of practicing law
Memberships / accreditations
Member of the Council, Intellectual Property Law Research Association of China Law Society
Research Fellow, Copyright Research Base of the National Copyright Administration
Expert of the Expert Database, China Intellectual Property News Agency
Project Research Fellow, Intellectual Property Center, Institute of Applied Law, the Supreme People's Court of China
Publications and/or speaking engagements

Monographs Systematic Research on the Legal System of Industrial Design, Intellectual Property Press, 2017 Principled Interpretation and Practical Rules of the Inventiveness Clause, Intellectual Property Press, 2023 Major Relevant Core Journal Papers Trial Logic of Standard Essential Patent Infringement Cases,China Patent and Trademark, Issue 2, 2026 Determination of FRAND Royalty Rates in Standard Essential Patent Cases, Political Science and Law Forum (Chinese Social Sciences Citation Index, CSSCI), Issue 6, 2024 On the Acceptance Conditions of Civil Cases Involving Pharmaceutical Patent Linkage, Intellectual Property Rights (CSSCI), Issue 7, 2024 Technical Effect and Inventiveness Determination of Crystal Form Patents, China Patent and Trademark, Issue 2, 2024 Supplementary Experimental Data and Inventiveness Judgment, China Patent and Trademark, Issue 3, 2023 Interpretation Rules of Patent Claims, China Patent and Trademark, Issues 1 & 2, 2023 Application of the TRIPS Agreement and Relevant International Conventions in China, Intellectual Property Rights (CSSCI), Issue 5, 2007